CHARLOTTESVILLE, Virginia, October, 13, 2016—RIVANNA, an innovative medical-device company that has developed a revolutionary pocket-sized ultrasound-based device for automated spinal and epidural anesthesia guidance, announced today $3.5 million in growth capital financing from a small group of existing and new individual investors.
The new investment will fuel RIVANNA’s increased global sales and marketing efforts aimed at establishing their flagship product, Accuro™, as the new standard-of-care for spinal and epidural anesthesia.
“We value our investors and their confidence in supporting RIVANNA’s mission to provide ground-breaking technology to aid anesthesia providers save time and improve efficiency, particularly in patients with challenging patient anatomy,” says RIVANNA Chairman and CEO Will Mauldin. “The company intends to steward this investment resourcefully as we continue our efforts to commercialize the Accuro device worldwide.”
Accuro is quickly being adopted by anesthesia providers at leading hospitals throughout the U.S. and abroad.
Accuro is the world’s first ultrasound-based system specifically designed to help anesthesia providers effortlessly apply spinal and epidural anesthesia. The Accuro features SpineNav3D™ and BoneEnhance™ innovations, which provide automated measurements of spinal midline and epidural depth in patients with challenging anatomy and high BMI.
ABOUT ACCURO
Accuro, by RIVANNA, is the world’s first ultrasound-based system specifically designed to help anesthesia providers effortlessly apply spinal and epidural anesthesia. Accuro’s revolutionary image-guidance platform features SpineNav3D, which automates measurements of the spinal midline, epidural depth and trajectory, and BoneEnhance, a technology innovation designed to visualize bone landmarks, making it easier and faster (compared to conventional ultrasound) to interpret the underlying image. Accuro supports a sterile environment for optimal patient safety. For anesthesia providers, certainty can be effortless with Accuro.
ABOUT RIVANNA
RIVANNA, located in Charlottesville, Virginia, is the innovative medical-device company that imagined, engineered and commercialized Accuro. Addressing the last frontier of image guidance in anesthesia, RIVANNA’s revolutionary application of automated 3D-navigation technology to ultrasound imaging of the spine gives anesthesia providers an intuitive extension of their hands to precisely administer epidural and spinal anesthesia. This proprietary imaging device is FDA 510(k)-cleared for spinal-anesthesia guidance and a variety of additional imaging applications. For information about the easy-to-use Accuro or the medical-device company RIVANNA, please visit rivannamedical.com.
Copyright © by Rivanna Medical, LLC. All rights reserved. RIVANNA, Accuro, BoneEnhance, and SpineNav3D are trademarks of Rivanna Medical, LLC.
The Accuro ultrasound system is covered by U.S. and foreign patents pending